AEWIN Technologies Co.,Ltd. (TPEX:3564)

Ligand Pharmaceuticals Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,518	2,285	1,969	2,463	2,017	1,761
Revenue Growth (YoY)	29.17%	16.05%	-20.05%	22.14%	14.49%	16.09%
Cost of Revenue	1,892	1,695	1,448	1,794	1,546	1,297
Gross Profit	625.97	590.94	521.71	669.67	470.76	464.15
Selling, General & Admin	287.96	285.77	282.33	284.97	242.18	238
Research & Development	214.86	198.78	178.66	173.2	148.85	148.82
Operating Expenses	516.7	495.77	463.68	457.34	391.28	382.9
Operating Income	109.28	95.16	58.02	212.33	79.47	81.25
Interest Expense	-22.8	-22.13	-20.3	-17.4	-5.96	-1.46
Interest & Investment Income	3.46	3.57	2.9	1.3	0.3	0.51
Currency Exchange Gain (Loss)	29.28	29.28	-12.95	11.53	-5.18	-13.44
Other Non Operating Income (Expenses)	-45.49	-39.51	-3.22	-18.31	0.78	0.35
EBT Excluding Unusual Items	73.72	66.37	24.45	189.45	69.41	67.21
Gain (Loss) on Sale of Assets	-	-	0.01	-0.03	0.15	-
Other Unusual Items	-	-	0.13	0.53	-	-
Pretax Income	73.72	66.37	24.59	189.94	69.56	67.21
Income Tax Expense	16.93	13.5	-2.03	36.2	24.94	14.06
Net Income	56.8	52.87	26.62	153.74	44.62	53.15
Net Income to Common	56.8	52.87	26.62	153.74	44.62	53.15
Net Income Growth	174.48%	98.66%	-82.69%	244.58%	-16.05%	11.50%
Shares Outstanding (Basic)	59	59	59	59	59	59
Shares Outstanding (Diluted)	59	59	59	60	59	59
Shares Change (YoY)	-0.54%	-0.05%	-0.65%	0.52%	-0.09%	10.29%
EPS (Basic)	0.97	0.89	0.45	2.60	0.75	0.90
EPS (Diluted)	0.96	0.89	0.45	2.58	0.75	0.90
EPS Growth	175.06%	97.78%	-82.56%	244.00%	-16.57%	1.33%
Free Cash Flow	66.99	125.36	168.13	233.34	-718.23	-63.44
Free Cash Flow Per Share	1.14	2.12	2.84	3.91	-12.11	-1.07
Dividend Per Share	0.890	0.890	0.350	0.800	0.600	0.600
Dividend Growth	154.29%	154.29%	-56.25%	33.33%	-	-
Gross Margin	24.86%	25.86%	26.49%	27.19%	23.34%	26.35%
Operating Margin	4.34%	4.16%	2.95%	8.62%	3.94%	4.61%
Profit Margin	2.25%	2.31%	1.35%	6.24%	2.21%	3.02%
Free Cash Flow Margin	2.66%	5.49%	8.54%	9.47%	-35.61%	-3.60%
EBITDA	147.18	133.03	93.7	241.52	94.95	98.44
EBITDA Margin	5.84%	5.82%	4.76%	9.80%	4.71%	5.59%
D&A For EBITDA	37.91	37.87	35.67	29.19	15.48	17.19
EBIT	109.28	95.16	58.02	212.33	79.47	81.25
EBIT Margin	4.34%	4.16%	2.95%	8.62%	3.94%	4.61%
Effective Tax Rate	22.96%	20.34%	-	19.06%	35.85%	20.92%

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.